[ Price : $8.95]
A Clinical Trial Vanguard online column explains how a 2022 FDA master protocol guidance has not kept pace with non-oncology baske...[ Price : $8.95]
FDA removes partial clinical hold against MacroGenics Phase 2 LINNET study evaluating the investigational cancer therapy lorigerli...[ Price : $8.95]
An FDA Matters column calls on FDA to fully enforce the laws against mass compounding of approved drugs that are not in shortage.[ Price : $8.95]
FDA warns Newport Beach, CA-based physician Ehsan Sadri about failing to follow the investigational plan in two clinical trials.[ Price : $8.95]
FDA plans a two-day public workshop next month aimed at improving how pregnancy registries are designed and used to assess the saf...[ Price : $8.95]
Organogenesis says it has reached agreement with FDA that clears the way for a rolling BLA submission for its knee osteoarthritis ...[ Price : $8.95]
FDA warns Glens Falls, NY-based Medline Industries about Quality System violations in its manufacturing and assembly of cardiovasc...[ Price : $8.95]
FDA solicits applications for its new READI-Home innovation challenge to use medical technology in the home to reduce or prevent h...